Sumitomo Pharma America Inc - Company Profile
Powered by 
All the data and insights you need on Sumitomo Pharma America Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Sumitomo Pharma America Inc Strategy Report
- Understand Sumitomo Pharma America Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sumitomo Pharma America Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Sumitomo Pharma America Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 19 Oct 2021 | Lorem |
| Sumitomo subsidiary Sunovion plans OLE and active comparator Phase III trials for SEP-363856 in schizophrenia on top of pivotal trial, executive says | 30 May 2019 | Shuan Sim |
| Boston Biomedical’s napabucasin Phase III trials’ enrollment 80% complete; plans checkpoint inhibitor combo studies for glioblastoma and solid tumor assets in 2019, CMO says | 26 Oct 2018 | Shuan Sim |
| NeuroDerm's ND0612H likely to be tried prior to Duodopa or DBS in Parkinson's; device advantages over competitors – experts | 22 Mar 2017 | Hamish McDougall |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer